Moreover, an animal study has confirmed that inhibiting the p53 pathway can suppress cardiac fibroblast activation and mitigate the progression of myocardial fibrosis following myocardial infarction (Tamaki et al., 2013). This evidence concerns the gene TP53 and Myocardial fibrosis.